Asad Zaidi
Overview
Explore the profile of Asad Zaidi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
2820
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simms I, Charlett A, Colon-Gonzalez F, Blomquist P, Blomquist P, Lake I, et al.
Epidemiol Infect
. 2025 Feb;
153:e28.
PMID: 39911069
The Flexible Farrington Algorithm (FFA) is widely used to detect infectious disease outbreaks at national/regional levels on a weekly basis. The rapid spread of SARS-CoV-2 alongside the speed at which...
2.
Aziz N, Twohig K, Sinnathamby M, Zaidi A, Aliabadi S, Groves N, et al.
Influenza Other Respir Viruses
. 2024 May;
18(5):e13308.
PMID: 38736251
No abstract available.
3.
Sinnathamby M, Zaidi A, Twohig K, Aliabadi S, Aziz N, Groves N, et al.
Influenza Other Respir Viruses
. 2023 Nov;
17(11):e13204.
PMID: 38019701
The emergence of the SARS-CoV-2 Beta (B.1.351) variant in November 2020 raised concerns of increased transmissibility and severity. We describe the epidemiology of 949 confirmed SARS-CoV-2 Beta variant cases in...
4.
Twohig K, Harman K, Zaidi A, Aliabadi S, Nash S, Sinnathamby M, et al.
Epidemiol Infect
. 2023 Sep;
151:e169.
PMID: 37726109
Whole-genome sequencing (WGS) information has played a crucial role in the SARS-CoV-2 (COVID-19) pandemic by providing evidence about variants to inform public health policy. The purpose of this study was...
5.
Tessier E, Webster H, Aziz N, Flannagan J, Zaidi A, Charlett A, et al.
Influenza Other Respir Viruses
. 2023 May;
17(4):e13139.
PMID: 37123814
Background: The COVID-19 pandemic has had disproportionate impact on vulnerable populations including those with learning disabilities. Assessing the incidence and risk of death in such settings can improve the prevention...
6.
Aziz N, Nash S, Zaidi A, Nyberg T, Groves N, Hope R, et al.
J Infect
. 2023 Apr;
87(1):e8-e11.
PMID: 37100176
No abstract available.
7.
Allen H, Tessier E, Turner C, Anderson C, Blomquist P, Simons D, et al.
Epidemiol Infect
. 2023 Mar;
151:e58.
PMID: 36938806
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant (B.1.1.529) rapidly replaced Delta (B.1.617.2) to become dominant in England. Our study assessed differences in transmission between Omicron and Delta...
8.
Zaidi A, Harris R, Hall J, Woodhall S, Andrews N, Dunbar K, et al.
Emerg Infect Dis
. 2022 Dec;
29(1):127-132.
PMID: 36529456
A single SARS-CoV-2 vaccine dose reduces onward transmission from case-patients. We assessed the potential effects of receiving 2 doses on household transmission for case-patients in England and their household contacts....
9.
Aiano F, McOwat K, Obi C, Powell A, Flood J, Bhardwaj S, et al.
BMC Public Health
. 2022 Oct;
22(1):1845.
PMID: 36183069
Background: In England, the emergence the more transmissible SARS-CoV-2 variant Alpha (B.1.1.7) led to a third national lockdown from December 2020, including restricted attendance at schools. Nurseries, however, remained fully...
10.
Dabrera G, Allen H, Zaidi A, Flannagan J, Twohig K, Thelwall S, et al.
Euro Surveill
. 2022 May;
27(20).
PMID: 35593163
BackgroundThe emergence of the SARS-CoV-2 Alpha variant in England coincided with a rapid increase in the number of PCR-confirmed COVID-19 cases in areas where the variant was concentrated.AimOur aim was...